Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Portrait de Paul Jai Sekhri
Leeftijd : 62
Vermogen : 9 952 852 USD
Belangrijkste bedrijven : Veeva Systems Inc. - Ipsen S.A. - Compugen Ltd. - Pharming Group N.V. - Longboard Pharmaceuticals, Inc. - BiomX Inc.
Overzicht 
Founder of Cerimon Pharmaceuticals, Inc., Paul Jai Sekhri is an American businessperson who has been at the helm of 10 different companies and holds the position of Chairman of Compugen Ltd., Chairman of Pharming Group NV, President, Chief Executive Officer & Director at eGenesis, Inc., Venture Partner at Medicxi Ventures (Jersey) Ltd. and Chairman for Pharming NV.

He is also Member of Ontario Institute for Cancer Research and Managing Director & Operating Partner at Tarrant Capital IP LLC and on the board of 16 other companies.

In his past career he occupied the position of Chairman for moksha8 Pharmaceuticals, Inc., Chairman at Petra Pharma Corp., Chairman at Topas Therapeutics GmbH, President & Chief Executive Officer for Cerimon Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Lycera Corp., Chief Strategy Officer & EVP-Business Development at Teva Pharmaceutical Industries Ltd., Venture Partner at MPM Capital Inc, Partner-Healthcare Investments at New Leaf Venture Partners LLC, Member-Patrons Council at The Carnegie Hall Society, Inc., President & Chief Business Officer at ARIAD Pharmaceuticals, Inc., Partner at Sprout Group, Senior Vice President-Integrated Care at Sanofi, Inc., Operating Partner & Head-Biotechnology Operations at TPG Biotech Equity LP, Senior VP, Head-Global Search & Evaluation at Novartis Pharma AG, Senior Vice President-Integrated Care at Sanofi SA and Operating Partner at Highline Therapeutics, Inc.

Mr. Sekhri received an undergraduate degree from the University of Maryland and a graduate degree from the University of Maryland School of Medicine.


Posities en verantwoordelijkheden van Paul Jai Sekhri 
NaamTitel Van
Veeva Systems Inc.
(Geavanceerde medische apparatuur & technologie)
Independent Director 2014
Ipsen S.A.
(Farmaceutische producten)
Independent Director 2018
Compugen Ltd.
(Biotechnologie & Medisch Onderzoek)
Chairman 2017
Pharming Group N.V.
(Farmaceutische producten)
Chairman 2016
Longboard Pharmaceuticals, Inc.
(Biotechnologie & Medisch Onderzoek)
Director 2020
BiomX Inc.
(Biotechnologie & Medisch Onderzoek)
Independent Director 2020
Global Alliance for TB Drug Development Director -
Cita NeuroPharmaceuticals, Inc. Director -
Metropolitan Opera Association, Inc. Director 2018
Pharming NV Chairman -
Cancer Research Institute Director -
The Caramoor Center for Music & the Arts, Inc. Director -
Ipsen Pharma SAS Independent Director -
Orchestra of St. Luke's Director 2018
The BioExec Institute, Inc. Director -
The English Concert in America, Inc. Director 2017
Young Concert Artists, Inc. Director -
eGenesis, Inc. President, Chief Executive Officer & Director 2019
The Knights Director 2017
LikeMinds, Inc. (Massachusetts) Director -
Ontario Institute for Cancer Research Member -
Tarrant Capital IP LLC Managing Director & Operating Partner -
Medicxi Ventures (Jersey) Ltd. Venture Partner 2020


Belangnemingen van Paul Jai Sekhri 
NaamAandelen%Totale waarde
Veeva Systems Inc. (VEEV)
(Geavanceerde medische apparatuur & technologie)
29 2350,021%9 705 435 USD
Pharming Group N.V. (PHARM)
(Farmaceutische producten)
184 3300,029%197 792 USD
BiomX Inc. (PHGE)
(Biotechnologie & Medisch Onderzoek)
12 5000,044%49 625 USD
Longboard Pharmaceuticals, Inc. (LBPH)
(Biotechnologie & Medisch Onderzoek)
00,0000%0 USD


Paul Jai SekhriPersoonlijk netwerk 
Meest gelezen nieuws 
22/09WILLIAM ACKMAN : Ackman's Pershing Square fonds stijgt bij beursdebuut Universal
MR
24/09CATHIE WOOD : Chinese maatregelen tegen bitcoin opnieuw een klap voor Cathie Woods ARK ETF
MR
15/09BRAD SMITH : Microsoft kondigt inkoop van eigen aandelen aan tot $60 mrd, verhoogt dividend
MR
14/09STEPHEN SCHERR : Goldman Sachs benoemt Coleman als nieuwe CFO, ter vervanging van Scherr
MR
15/09ILHAM KADRI : Activist Bluebell Capital wil ontslag CEO Solvay
AM
Meer nieuws


© 2021 People and Ownership :   
Paul Jai Sekhri Verbindingen